Executive summary · 30-second read
Compound DT-204 DTC content — for less, in less time.
One-page summary for forwarding up. OVYN is the MLR-grade production layer for pharma DTC — three trademarked architecture layers (Intelligence · Content Engine · Activation · Measurement), one signed-off output. The cost math, the timeline, the outcomes — without the platform tour.
The headline
~50% cheaper.
10× faster.
Compound DT-204 DTC content production at roughly half the cost of a traditional agency line — and at 10× the version output per brief. MLR-aware, Veeva-archived, deployed across every channel from one approval.
The math
What an Compound DT-204 campaign costs today vs. with OVYN.
Traditional agency · per quarter
$84,000
Strategy + creative direction$28,000
Production · variants + adaptations$38,000
MLR prep + revision cycles$12,000
Reporting + insights$6,000
Indegene 2024 industry benchmark · DTC creative line for a single Compound DT-204-scale campaign.
OVYN · same campaign
$42,000
Brand brain config (one-time, amortized)$8,000
Production · 40+ versions$22,000
MLR rail · pre-cleared submissions$8,000
Reporting · auto-generated$4,000
OVYN tier 2 engagement · same brief, same audience, same MLR throughput. Savings hit 60% in tier 3 with the full performance loop.
Net to Demo Therapeutics: $42K saved per campaign. Across an 8-campaign annual program, that's $336K freed up — which roughly equals one additional named indication or one new audience cohort fully funded.
$336K / yr
The timeline
From contract to first MLR-ready content in your queue.
Week 1
Scope & kickoff
Confirm tier, audience, indication priorities. Materials exchange begins.
Weeks 2–4
Build
Veeva connector, claims library, ISI variants, brand voice rules — all loaded. Compliance rail tuned.
Week 5
Validation
Test variants generated for your team's review. Compliance rail validated against your brand parameters.
Week 6+
Live work
First brief in your MLR queue. Cadence established. Performance loop starts.
Or skip the build: send a brief on day one and we deliver 12 MLR-scored versions in 48 hours — same engine, no contract. Zero-commitment pilot.
The outcomes · what shifts day one
Three things your team feels by the second week live.
01
Faster MLR
Pre-check rail catches what would flag before MLR sees it. Reviewers stop seeing the same fair-balance and comparative-claim issues on repeat. First-pass approval climbs to 80% by month 3.
02
More variants
16 formats per brief, automatically. Email banners, eBlasts, Reels, carousels, statics, display, detail aids, IVA frames, patient brochures. Same brief, every channel.
03
Audience-tuned content
Caregiver hooks, newly-diagnosed disease state, HCP cardiology — each cohort gets variants written for them, not retrofitted from one master version.
The pitch · in one paragraph
OVYN is an AI content studio purpose-built for pharma and health/wellness. We don't replace your stack — we sit alongside it. Your Veeva PromoMats stays your archive. Your media agency keeps the buy. We compress the production layer that sits between strategy and deployment, with a compliance rail that catches what would flag MLR before MLR sees it. For Compound DT-204 specifically: ~50% cheaper creative, 6 weeks to live, and a 48-hour pilot offer with zero commitment to test the work first.
Designed to forward up. Cmd-P (or right-click → Save as PDF) for a printable version. Single page when you choose "fit to width" + remove headers.
Forward thisOne click to the right page for whoever you need to loop in.
What's underneathArchitecture · advisors · published thinking.
Talk to us30 minutes with Maha + Zein. No deck, no sales motion. We answer your questions.